This is a muscus regulator and anti inflamantry drug. . .
acebrophylline, a xanthine derivative, is prescribed as a bronchodilator for the treatment of bronchial asthma and copd in adults. Acebrophylline alter mucus gel secretion phase by lowering viscosity and increasing the serous gel phase. By augmenting ciliary motility, acebrophylline increases the mucociliary clearance. Precautions
acebrophylline is contraindicated in patients with hypotension, acute myocardial infarction, impaired hemodynamics, hepatic or/and renal disorders, ambroxol allergy, gi disorders, convulsion, arrhythmia, cad, cardiac insufficiency and hyperthyroidism.
acebrophylline 200mg cap. . .